Astarte Medical, a clinical intelligence company leveraging data and digital tools to improve health outcomes in the first 1,000 days, secured $7.6 million in Series A-1 financing. Investors in the round include Viking Global Investors, Lunsford Capital, Ben Franklin Technology Partners, OCA Ventures, Next Act Fund, Capita3, Leatherneck Ventures, and Social Venture Circle.
The company will use the funds to scale the sales of NICUtrition®, its EMR-integrated, clinical decision support platform addressing critical, unmet needs in the NICU like malnutrition, suboptimal growth, and racial disparities in care. Read more.
